Zobrazeno 1 - 10 of 74 pro vyhledávání: '"Federico Bolognani"'
1
Akademický článek
KSRP modulation of GAP-43 mRNA stability restricts axonal outgrowth in embryonic hippocampal neurons.
Autor: Clark W Bird, Amy S Gardiner, Federico Bolognani, Daniel C Tanner, Ching-Yi Chen, Wei-Jye Lin, Soonmoon Yoo, Jeffery L Twiss, Nora Perrone-Bizzozero
Publikováno v: PLoS ONE, Vol 8, Iss 11, p e79255 (2013)
The KH-type splicing regulatory protein (KSRP) promotes the decay of AU-rich element (ARE)-containing mRNAs. Although KSRP is expressed in the nervous system, very little is known about its role in neurons. In this study, we examined whether KSRP reg
Externí odkaz: https://doaj.org/article/5d44ab04027f458c9db3bf5d50a11277
Zobrazit plný text záznamu
2
Akademický článek
Increased Expression of Axogenesis-Related Genes and Mossy Fibre Length in Dentate Granule Cells from Adult HuD Overexpressor Mice
Autor: Nora I Perrone-Bizzozero, Daniel C Tanner, Joanna Mounce, Federico Bolognani
Publikováno v: ASN Neuro, Vol 3 (2011)
The neuronal RNA-binding protein HuD plays a critical role in the post-transcriptional regulation of short-lived mRNAs during the initial establishment and remodelling of neural connections. We have generated transgenic mice overexpressing this prote
Externí odkaz: https://doaj.org/article/d88cb37aaab44131908f8bc276ea521b
Zobrazit plný text záznamu
3
The Montefiore-Einstein Rigidity Scale-Revised (MERS-R): Development, administration, reliability, and validity in child and adult Autism Spectrum Disorder (ASD)
Autor: Bonnie P. Taylor, Jianyou Liu, Wenzhu Mowrey, Eckhart Eule, Federico Bolognani, Eric Hollander
Publikováno v: Journal of Psychiatric Research. 147:142-147
Rigidity contributes to severity and functional impairment in autism spectrum disorder (ASD). There is an unmet need for a valid, reliable, and sensitive outcome measure to assess rigidity in ASD.To develop and validate the Montefiore-Einstein Rigidi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27289235a4919e076fffa940a71701e
https://doi.org/10.1016/j.jpsychires.2021.12.055
Zobrazit plný text záznamu
4
Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: An open-label phase 1 and 2 metabolic balance trial
Autor: Johanna Eliasson, Mark K. Hvistendahl, Nanna Freund, Federico Bolognani, Christian Meyer, Palle B. Jeppesen
Publikováno v: Eliasson, J, Hvistendahl, M K, Freund, N, Bolognani, F, Meyer, C & Jeppesen, P B 2022, ' Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome : An open-label phase 1 and 2 metabolic balance trial ', Journal of Parenteral and Enteral Nutrition, vol. 46, no. 7, pp. 1639-1649 . https://doi.org/10.1002/jpen.2362
Background: Apraglutide is a novel long-acting glucagon-like peptide-2 (GLP-2) analog designed for once-weekly subcutaneous dosing, with the potential to increase fluid and nutrient absorption by the remnant intestine of patients who have short bowel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c5dbd7b3d843352b85f3ddcbc24586
https://pubmed.ncbi.nlm.nih.gov/35233802
Zobrazit plný text záznamu
5
Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure:Findings from a placebo-controlled, randomized phase 2 trial
Autor: Johanna Eliasson, Nanna Freund, Mark Hvistendahl, Federico Bolognani, Christian Meyer, Palle Jeppesen
Publikováno v: Eliasson, J, Hvistendahl, M K, Freund, N, Bolognani, F, Meyer, C & Jeppesen, P B 2022, ' Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure : Findings from a placebo-controlled, randomized phase 2 trial ', Journal of Parenteral and Enteral Nutrition, vol. 46, no. 4, pp. 896-904 . https://doi.org/10.1002/jpen.2223
Background: Treatment with glucagon-like peptide-2 (GLP-2) analogs improve intestinal adaptation in patients with short bowel syndrome–associated intestinal failure (SBS-IF) and may reduce parenteral support requirements. Apraglutide is a novel, lo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0717b3aa7452740633a95d106988a0be
https://curis.ku.dk/ws/files/321651958/Apraglu_de_a_novel_glucagon_like.pdf
Zobrazit plný text záznamu
7
Decreased Cortical Thickness in the Anterior Cingulate Cortex in Adults with Autism
Autor: Josselin Houenou, Juergen Dukart, Charles Laidi, Anouck Amestoy, Alexandru Gaman, Isabelle Scheid, Jennifer Boisgontier, Edouard Duchesnay, Marc-Antoine d'Albis, Richard Delorme, Elie Toledano, Stefan Holiga, Christian Czech, Amicie de Pierrefeu, Marion Leboyer, Myriam Ly-Le Moal, J. Petit, Federico Bolognani, S. Hotier, Céline Bouquet
Publikováno v: Journal of Autism and Developmental Disorders. 49:1402-1409
Autism spectrum disorder (ASD) is a developmental disorder underdiagnosed in adults. To date, no consistent evidence of alterations in brain structure has been reported in adults with ASD and few studies were conducted at that age. We analyzed struct
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5ebad4ac77c499481924e6315fcb156
https://doi.org/10.1007/s10803-018-3807-3
Zobrazit plný text záznamu
8
Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom
Autor: Richard Houghton, Federico Bolognani, Chuang Liu
Publikováno v: Autism Research. 11:1690-1700
Psychiatric comorbidities and use of psychotropic medications are common among patients with autism spectrum disorder (ASD). However, most previous research used data from the United States (US) and few studies have compared medication use in ASD to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2fc3386f2e6cce70c207a853c7d64be9
https://doi.org/10.1002/aur.2040
Zobrazit plný text záznamu
9
Increased risk of ADHD in families with ASD
Autor: Manuel Bouvard, Hugo Peyre, Marion Leboyer, Richard Delorme, Céline Bouquet, Garry D. Honey, Anita Beggiato, Isabelle Scheid, Myriam Ly-Le Moal, Thomas Bourgeron, Marion Poumeyreau, Frédérique Amsellem, Anouck Amestoy, Federico Bolognani, Anna Maruani, Mathilde Septier, Alexandru Gaman
Publikováno v: European Child and Adolescent Psychiatry
European Child and Adolescent Psychiatry, 2019, 28 (2), pp.281-288. ⟨10.1007/s00787-018-1206-0⟩
Attention Deficit and Hyperactive Disorder (ADHD) and Autism Spectrum Disorders (ASD) are frequent comorbid neurodevelopmental conditions and the overlap between both disorders remains to be delineated. A more complete understanding of the shared gen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b985ae9b883984ae9cb5b4e2c0bb18
https://doi.org/10.1007/s00787-018-1206-0
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje